Literature DB >> 25527709

Pregnane X receptor modulates the inflammatory response in primary cultures of hepatocytes.

Mengxi Sun1, Wenqi Cui1, Sarah K Woody1, Jeff L Staudinger2.   

Abstract

Bacterial sepsis is characterized by a rapid increase in the expression of inflammatory mediators to initiate the acute phase response in liver. Inflammatory mediator release is counterbalanced by the coordinated expression of anti-inflammatory molecules such as interleukin 1 receptor antagonist (IL1-Ra) through time. This study determined whether activation of pregnane X receptor (PXR, NR1I2) alters the lipopolysaccharide (LPS)-inducible gene expression program in primary cultures of hepatocytes (PCHs). Preactivation of PXR for 24 hours in PCHs isolated from wild-type mice suppressed the subsequent LPS-inducible expression of the key inflammatory mediators interleukin 1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α (TNFα) but not in PCHs isolated from Pxr-null (PXR-knockout [KO]) mice. Basal expression of key inflammatory cytokines was elevated in PCHs from PXR-KO mice. Stimulation of PCHs from PXR-KO mice with LPS alone produced enhanced levels of IL-1β when compared with wild-type mice. Experiments performed using PCHs from both humanized-PXR transgenic mice as well as human donors indicate that prolonged activation of PXR produces an increased secretion of IL1-Ra from cells through time. Our data reveal a working model that describes a pivotal role for PXR in both inhibiting as well as in resolving the inflammatory response in hepatocytes. Understanding the molecular details of how PXR is converted from a positive regulator of drug-metabolizing enzymes into a transcriptional suppressor of inflammation in liver will provide new pharmacologic strategies for modulating inflammatory-related diseases in the liver and intestine.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527709      PMCID: PMC4352581          DOI: 10.1124/dmd.114.062307

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  56 in total

Review 1.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

2.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.

Authors:  Yatrik M Shah; Xiaochao Ma; Keiichirou Morimura; Insook Kim; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-12-14       Impact factor: 4.052

Review 4.  Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms.

Authors:  Danielle A A Hollman; Alexandra Milona; Karel J van Erpecum; Saskia W C van Mil
Journal:  Biochim Biophys Acta       Date:  2012-07-20

5.  Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.

Authors:  Pankaj B Desai; Srikanth C Nallani; Rucha S Sane; Linda B Moore; Bryan J Goodwin; Donna J Buckley; Arthur R Buckley
Journal:  Drug Metab Dispos       Date:  2002-05       Impact factor: 3.922

6.  Pregnane X receptor is SUMOylated to repress the inflammatory response.

Authors:  Gang Hu; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2010-08-18       Impact factor: 4.030

7.  Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor.

Authors:  Dan E Brobst; Xunshan Ding; Katrina L Creech; Bryan Goodwin; Brian Kelley; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2004-04-01       Impact factor: 4.030

8.  Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes.

Authors:  Srikanth C Nallani; Bryan Goodwin; Arthur R Buckley; Donna J Buckley; Pankaj B Desai
Journal:  Cancer Chemother Pharmacol       Date:  2004-06-03       Impact factor: 3.333

9.  Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.

Authors:  Anne P Beigneux; Arthur H Moser; Judy K Shigenaga; Carl Grunfeld; Kenneth R Feingold
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

Review 10.  Physiologic role of interleukin-1 receptor antagonist.

Authors:  W P Arend; C Gabay
Journal:  Arthritis Res       Date:  2000-05-19
View more
  24 in total

1.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 2.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

3.  SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.

Authors:  Wenqi Cui; Mengxi Sun; Nadezhda Galeva; Todd D Williams; Yoshiaki Azuma; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2015-06-10       Impact factor: 3.922

Review 4.  Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.

Authors:  Pankajini Mallick; Guncha Taneja; Bhagavatula Moorthy; Romi Ghose
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-02-22       Impact factor: 4.481

5.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

Authors:  Akira Honda; Teruo Miyazaki; Junichi Iwamoto; Takeshi Hirayama; Yukio Morishita; Tadakuni Monma; Hajime Ueda; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Tadashi Ikegami
Journal:  J Lipid Res       Date:  2019-10-23       Impact factor: 5.922

Review 6.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

7.  Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation.

Authors:  Tao Zhou; Wen-ting You; Zeng-chun Ma; Qian-de Liang; Hong-ling Tan; Cheng-rong Xiao; Xiang-lin Tang; Bo-li Zhang; Yu-guang Wang; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

8.  Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.

Authors:  Shilong Zhong; Weichao Han; Chuqi Hou; Junjin Liu; Lili Wu; Menghua Liu; Zhi Liang; Haoming Lin; Lili Zhou; Shuwen Liu; Lan Tang
Journal:  AAPS J       Date:  2016-09-28       Impact factor: 4.009

Review 9.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 10.  Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.

Authors:  Peter Oladimeji; Hongmei Cui; Chen Zhang; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-06-23       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.